Category: Mazor Robotics Ltd.
Mazor Robotics says it won approval from the China Food & Drug Administration for its Renaissance robot-assisted surgery device for spine procedures.
Mazor Surgical's robot-guided system helps boost accuracy and lower radiation exposure in placing pedicle screws in adolescent scoliosis patients, researchers report.
Without naming names, Forbes contributor and Permanente Medical Group CEO Dr. Robert Pearl calls out makers of robot-assisted surgical systems for their role in 'increasing prices for products that don't add much value.'
Updated May 1, 2014, with comments from Intuitive Surgical.
Surgical robots are taking one for the team, becoming the latest poster child for over-priced U.S. healthcare.
Mazor Robotics (NSDQ:MZOR) said it's planning the début of a new brain module for its Renaissance robotic surgery system next week.
Mazor Robotics links up with an unnamed group purchasing giant, while RTI Surgical joins forces with Yankee Alliance Members.
Mazor Robotics (NSDQ:MZOR) announced a deal with an unnamed group purchasing organization for its flagship Renaissance robotic surgery system.
Mazor Robotics rakes in nearly $47 million from a $17-per-share stock offering after the underwriters trigger an over-allotment worth about $6 million.
Mazor Robotics (NSDQ:MZOR) said it raked in a total of $46.9 million from a stock offering announced last week, including a last-minute $5.9 million addition from an over-allotment.
The Caesarea, Israel-based robotics company makes the Renaissance robotic surgery system for spinal surgeries.
Mazor Robotics pricing a stock offering at $17 per share, saying the total proceeds could approach $41 million.
Mazor Robotics (NSDQ:MZOR) said it plans to offer 2.4 million shares of stock at $17 apiece, for total proceeds of $40.8 million.